drugset / Trial / NCT01546389

Sanaria™ PfSPZ Challenge Vaccine

NCT01546389

RandomizedParallel-groupDouble-blind

Summary

This study will randomize 30 healthy adult participants to one of three cohorts comprised of six groups of 5 individuals per group to simultaneously receive PfSPZ Challenge via the ID route. The goal will be to determine the optimal dose required to achieve 100% infectivity (ID100) of adult volunteers with P. falciparum malaria.

Timeline

Start
2012-04
Primary completion
2013-04
Completion
2013-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Chloroquine Small molecule 300 mg Oral

Indications